HQL · Forms 3, 4, 5
Insider trades at abrdn Life Sciences Investors
No open-market insider buys or sells at abrdn Life Sciences Investors in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for abrdn Life Sciences Investors (HQL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for abrdn Life Sciences Investors in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Chris LaVictoire Mahai | Director | Buy | 527 | $19.92 | $10K | Form 4 | |
| Chris LaVictoire Mahai | Director | Became an insider (Form 3) | Form 3 | ||||
| Heather Carter Reilly | Vice President | Became an insider (Form 3) | Form 3 | ||||
| Christian Pittard | Director | Buy | 7,923 | $16.88 | $134K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 41,623 | $14.14 | $589K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 6,989 | $14.10 | $99K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 40,208 | $14.07 | $566K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 24,328 | $13.99 | $340K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 2,026 | $13.99 | $28K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 700 | $14.13 | $10K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 15,116 | $14.28 | $216K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 14,083 | $14.04 | $198K | Form 4 | |
| Saba Capital Management, L.P. | 10% owner | Sell | 23,723 | $13.89 | $330K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.